NEJM This Week — September 22, 2022
Featuring articles on glycemic outcomes of glycemia reduction, microvascular outcomes of glycemia reduction, dapagliflozin in heart failure with preserved ejection fraction, and an antisense oligonucleotide for SOD1 ALS; a review article on Burkitt’s lymphoma; a case report of a man with chronic diarrhea and autoimmune enteropathy; and Perspective articles on the law of licensure and quality regulation, on pushing back with pills, and on the seeds of ignorance.
